Volastra Therapeutics logo
VerifiedBiotechnology· Founded 2019

Volastra Therapeutics

Volastra Therapeutics is a New York-based drug discovery and therapeutics company pioneering novel approaches to treating cancer by exploiting chromosomal instability (CIN), cancer’s most targetable vulnerability. Founded by Lewis Cantley, Ph.D, Olivier Elemento, Ph.D, and Samuel Bakhoum, M.D, Ph.D, Volastra is advancing a novel synthetic lethal and immune activating pipeline. Leading its portfolio, Volastra has two KIF18A inhibitors in Phase 1 clinical trials for cancers with high levels of chromosomal instability.

7-day free trial · no credit card

HeadquartersNew York, United StatesEmployees40(11 to 50)Annual revenue$1M to <$10MFounded year2019Websitevolastratx.comLinkedIn profileLinkedIn

Verified contacts

41

available on Kipplo

LinkedIn employees

40

11 to 50 range

Open roles

no listings

Distinct roles

28

indexed titles

Tech stack

2

tools in use

Monthly traffic

133

organic / mo

Sign up free to see all 41 verified contacts at Volastra Therapeutics

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Decision-makers and verified team members

41 contacts with verified email or phone · masked until revealed.

Sign up free →

Top roles at Volastra Therapeutics

28 distinct titles indexed · top 10 shown.

  • 6shareholder
  • 2senior research associate
  • 2senior scientist
  • 2senior vice president, cmc
  • 1()
  • 1, (,)
  • 1associate director, business & portfolio strategy
  • 1board member
  • 1ceo
  • 1chief operating officer
  • +18more titles

Sign up to unlock all 41 contacts at Volastra Therapeutics

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Sign up to reveal 41 verified contacts at Volastra Therapeutics

7-day trial · no credit card · cancel anytime · only pay for verified records.

Trusted by sales, marketing, and GTM engineering teams.

Volastra Therapeutics | Kipplo Discover